Skip to content

Depression: all studies

Page 37 of 1,034: studies 361 to 370 of 10,336, newest first. Back to the depression overview

Research

Bupropion-Memantine Combination in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression.

Human psychopharmacology May 2026 Juan Miguel Riestra, Yaxel Levin-Carrion, Roshan Sutar et al.

Treatment-resistant depression (TRD) remains a formidable challenge in psychiatry, with nearly one-third of patients with major depressive disorder (MDD) failing to respond adequately to first-line pharmacological treatments. Pathophysiology in MDD has highlighted the N-methyl-D-aspartate (NMDA) glutamatergic system as a promising therapeutic target. In 2022, the US Food and Drug Administration...

Spirituality Among Older Adults With Depression: An Interpretative Phenomenological Study.

Journal of Nursing Scholarship May 2026 Wilawan Christraksa, Julia A Snethen, Julie L Ellis et al.

Spirituality is a crucial yet complex element of holistic nursing care, particularly when providing care for older adults with depression. In Thailand, depression poses a significant mental health challenge. Thai cultural values are deeply interwoven with individuals' beliefs, making spirituality a critical factor in addressing the care of older adults with depression. This study aimed to...

DOI: 10.1111/jnu.70082 (opens in new tab) Full text (opens in new tab) Coping mechanisms Geriatric depression Inner power Interpretative phenomenological analysis +2

Mindfulness for heart and mind: Mindfulness-based blood pressure reduction randomized clinical trial for depression symptoms.

Health Psychology May 2026 Surenmaa Sukhbaatar, Shufang Sun, Matthew M Scarpaci et al.

This study evaluated the effects of the Mindfulness-Based Blood Pressure Reduction (MB-BP) program on depression symptoms in individuals with elevated blood pressure (BP). Exploratory analyses examined whether childhood abuse or neglect moderated these effects. Adults with elevated BP (n = 201; ≥120/80 mmHg) were randomized to MB-BP (n = 101) or enhanced usual care (n = 100) and followed for 6...

Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie May 1, 2026 Carla Fonseca, F. Gouveia, Soraia Silva et al.

Depression is a highly prevalent and incident mental illness. Current pharmacological therapies fail in approximately 30-40% of patients, highlighting the urgent need for novel agents with pleiotropic effects. This preclinical study aimed to identify new antidepressants and cognitive modulators among five phytocannabinoids: cannabichromene, cannabidiol, cannabidivarin, cannabigerol and...

Impact of mindfulness-based interventions on stress, anxiety and depression among nursing students: A systematic review and meta-analysis.

Nurse Education in Practice May 1, 2026 Bin Shen, Jianjiang Liu, Qiaoxia Lv

AIM This updated systematic review and meta-analysis aimed to evaluate the effectiveness of mindfulness-based interventions (MBIs) in reducing stress, anxiety, depression and improving mindfulness among nursing students. BACKGROUND Nursing students often experience significant psychological distress due to the demanding academic and clinical environments of nursing education. MBIs have been...

Cost-effectiveness of virtual Mindfulness-Based Cognitive Therapy on pregnancies at high risk of perinatal depression.

Pregnancy May 2026 Riane Bradbury-Huang, Lindsay Quinn, Ellen L Tilden et al.

Previous research has shown that preventive counseling for women at high risk of perinatal depression leads to a reduction in the development of perinatal depression and is cost-effective. Barriers of cost, transit, time, and staffing limit accessibility of these services. We examined whether a theoretical, virtual, group, social worker (SW)-led Mindfulness-Based Cognitive Therapy (MBCT)...

DOI: 10.1002/pmf2.70305 (opens in new tab) Full text (opens in new tab) Mindfulness‐based cognitive therapy Cognitive behavioral therapy Cost‐effectiveness analysis Perinatal depression +2

Temporal Precedence of Distress Tolerance in Predicting Anxiety and Depression: A Daily Diary Approach During Mindfulness-Based Intervention.

Behavior Therapy May 1, 2026 Yanjuan Li, Amy Hu, Yiran Ding et al.

This study used a daily diary method to examine the temporal relationship between distress tolerance (DT), anxiety, and depression during a mindfulness-based intervention (MBI). A total of 83 participants with high emotional distress completed daily diaries of mindfulness, DT, anxiety and depression over one week before, during, and after the intervention. Linear mixed models showed significant...

DOI: 10.1016/j.beth.2025.11.006 (opens in new tab) Full text (opens in new tab) Distress tolerance Emotional distress Mechanism Mindfulness-based intervention +1

Depression, Anxiety and Stress in Meditation Practitioners versus Non Meditation Practitioners: A Cross-sectional Study

Journal of Clinical and Diagnostic Research May 1, 2026 Ram Kumar Gupta, Abhishek Kumar Bhardwaj

Introduction: Recent rapid technological advancements and societal changes have dramatically transformed modern life, leading to a significant increase in mental health concerns. Meditation, an ancient practice, has gained considerable attention in recent years for its psychological and neurological benefits. Aim: To compare levels of depression, anxiety and stress between Meditation...

Brazilian Psychiatric Association Guidelines for pharmacological treatment of Major Depressive Disorder: An overview of systematic reviews and meta-analyses.

Revista Brasileira de Psiquiatria May 1, 2026 Marcelo Pinheiro Machado Adelino, Julia Diniz Grossi, Marcel Vella Nunes et al.

To synthesize evidence on pharmacological treatments for major depressive disorder (MDD) to inform updated Brazilian clinical guidelines. This overview included systematic reviews and meta-analyses published in the last 10 years, identified through MEDLINE, Cochrane Library, and SciELO. Eligible studies involved adults with MDD receiving pharmacological interventions. Risk of bias was assessed...

Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.

Cancer Reports May 1, 2026 Sepideh Hajivalizadeh, Kimia Farahmand, Kimia Kazemzadeh et al.

Depression is a prevalent comorbidity in cancer, yet conventional treatments show inconsistent efficacy. This review sought to provide a mechanism-based framework for managing cancer-related depression by exploring its unique pathophysiology and evaluating promising pharmacotherapies based on their alignment with these biological pathways. This narrative review synthesized evidence on promising...